Finance

Lists
Why is 688068 down 2.29%?
Dive Deeper
688068:SHA
Beijing Hotgen Biotech Co Ltd
CN¥ 75.80
-2.29%
(-1.78) 1D
10-р сарын 15, 15:00:02 (GMT+8)  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 688068...
Open
CN¥ 75.80
High
CN¥ 79.10
Low
CN¥ 75.00
Mkt. cap
7.15 тэрбум
Avg. vol.
2.31 сая
Volume
1.66 сая
52-wk high
CN¥ 214.78
52-wk low
CN¥ 73.44
EPS
-CN¥ 3.00
No. of employees
1 мян.
Open
CN¥ 75.80
High
CN¥ 79.10
Low
CN¥ 75.00
Mkt. cap
7.15 тэрбум
Avg. vol.
2.31 сая
Volume
1.66 сая
52-wk high
CN¥ 214.78
52-wk low
CN¥ 73.44
EPS
-CN¥ 3.00
No. of employees
1 мян.
News stories
From web sources and news partners
Profile
Hotgen Biotech, often simply referred to as Hotgen, is a Chinese biological technology company founded in 2005. It focuses on the manufacture of in-vitro diagnostic instruments and reagents. In September 2019, the company was listed on the Shanghai Stock Exchange. During the novel coronavirus pandemic, it specialized in making 2019-nCoV antigen diagnostic products, which obtained EU CE certification. Hotgen was formerly a constituent of the STAR 50 Index. Headquartered in Beijing, it also established presences in foreign markets, such as the United Kingdom, France, and Germany. The net profit of the company in 2021 exceeded 2.3 billion yuan, an increase of more than sixteen times from the previous year. In 2022, its RAT kits were distributed free of charge by the Hong Kong Government to the public. In November 2023, it attended the MEDICA Trade Fair in Düsseldorf. Wikipedia
About Beijing Hotgen Biotech Co Ltd
CEO-
Employees1.04 мян
Founded2005 оны 6-р сарын 23
Headquarters-
SectorHealth care
Previous reportsAll values in CNY
Loading Previous Earnings...
Revenue
Net income
All values in CNY
2025 оны 9-р сар
2025 оны 12-р сар
2026 оны 3-р сар
2026 оны 6-р сар
Revenue
105.80 сая
95.17 сая
116.03 сая
151.72 сая
Cost of goods sold
49.91 сая
40.31 сая
55.11 сая
36.50 сая
Cost of revenue
49.91 сая
40.31 сая
55.11 сая
36.50 сая
Research and development expenses
19.65 сая
94.81 сая
49.10 сая
46.03 сая
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
83.78 сая
99.31 сая
97.60 сая
127.34 сая
Operating expense
98.59 сая
204.82 сая
143.51 сая
186.68 сая
Total operating expenses
148.50 сая
245.13 сая
198.62 сая
223.17 сая
Operating income
-42.70 сая
-149.96 сая
-82.59 сая
-71.46 сая
Other non operating income
-273.76 мян
2.19 сая
-2.39 сая
2.09 сая
EBT including unusual items
-20.92 сая
-155.14 сая
-82.67 сая
-76.94 сая
EBT excluding unusual items
-28.82 сая
-122.01 сая
-69.59 сая
-76.99 сая
Income tax expense
4.59 сая
-6.98 сая
-5.78 мян
-796.34 мян
Effective tax rate
-21.96%
4.50%
0.01%
1.03%
Other operating expenses
-5.37 сая
6.99 сая
-2.96 сая
3.17 сая
Net income
-24.96 сая
-107.09 сая
-68.06 сая
-58.07 сая
Net profit margin
-23.59%
-112.52%
-58.66%
-38.27%
Earnings per share
-
-
-
-
Interest and investment income
14.98 сая
35.99 сая
15.44 сая
3.94 сая
Interest expense
-289.66 мян
-7.96 сая
-46.88 мян
-7.63 сая
Net interest expenses
14.69 сая
28.03 сая
15.39 сая
-3.69 сая
Depreciation and amortization charges
-
-
-
-
EBITDA
-21.62 сая
-129.90 сая
-62.53 сая
-53.46 сая
Gain or loss from assets sale
601.43 мян
-579.43 мян
-
6.83 мян
AI content may include mistakes. Learn more
Google аппс